Picture of Aequus Pharmaceuticals logo

AQS — Aequus Pharmaceuticals News Story

0.000.00%
ca flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: FDA Confirms Date To Providing Regulatory Guidance For Aequus’ Anti-Nausea Patch

March 7 (Reuters) - Aequus Pharmaceuticals Inc  AQS.V :
    * FDA CONFIRMS DATE TO PROVIDING REGULATORY GUIDANCE FOR
AEQUUS’
ANTI-NAUSEA PATCH
    * AEQUUS PHARMACEUTICALS - FDA WILL PROVIDE FEEDBACK TO CO'S
PRE-INVESTIGATIONAL NEW DRUG SUBMISSION BY APRIL END, 2018 FOR
AQS1303​

Source text for Eikon:  ID:nGNXbYp0f9 
Further company coverage:  AQS.V 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Aequus Pharmaceuticals

See all news